« Back
Improved T Cell Activation Bioassays for Development of Bispecific Antibodies and Engineered T Cell Immunotherapies
Improved T Cell Activation Bioassays for Development of Bispecific Antibodies and Engineered T Cell Immunotherapies
Submitted on 15 May 2017

Pete Stecha, Denise Garvin, Jim Hartnett, Frank Fan, Mei Cong and Zhi-jie Jey Cheng
Promega Corporation, 2800 Woods Hollow Rd, Madison, WI 53711
Poster Views: 1,588
View poster »
Poster Abstract
Immunotherapy aims to boost a patient’s own immune system to fight disease. In recent years, a variety of immunotherapy strategies aimed at inducing, strengthening or engineering T cell responses have emerged as promising approaches for the treatment of cancer and autoimmune disease.

Here we describe a platform of T cell activation bioassays for the development of CD3 bispecific antibodies and engineered T cell immunotherapies.

Specifically, we developed two bioluminescent reporter-based bioassays to measure T cell activation via CD3 (NFAT-RE) or CD3 + CD28 (IL-2 promoter). These

Corresponding author: richard.somberg@promega.comReport abuse »
Ask the author a question about this poster.
Ask a Question »

Creative Commons

Related Posters

High-throughput Carbonic Anhydrase Activity and Inhibitor Screening Assays
Suratna Hazra, Ph.D., Grigoriy Tchaga, Ph.D., and Gordon Yan, Ph.D.

A High-Throughput Assay to Measure Phosphoenolpyruvate Carboxykinase (PEPCK) Activity in Biological Samples
Shunan Li, Ph.D., Keith Cheung, Ph.D. Grigoriy Tchaga, Ph.D. Jianping Xu, Ph.D. and Gordon Yan, Ph.D. Acknowledments: Kyle Schmitt, Ph.D • Tanvi Gangakhedkar • Gustavo Chavarria, Ph.D. • Kwang Kim, Ph.D. • Robert Stephenson, Ph.D. • Hong Qu, Ph.D.

High-throughput detection of Glycine in biological samples based on a novel enzymatic assay
Gustavo Chavarria, Ph.D., Kyle Schmitt, Ph.D., Nidhi Tibrewal, Ph.D., Sonika Saddar, Ph.D., Preeti Saini, Ph.D., Grigoriy Tchaga, Ph.D. and Gordon Yan, Ph.D.

A High-throughput, Fluorescence-based Cholesterol Efflux Assay
Sonika Saddar, Tasnim Kothambawala, Nick Chacos, Preeti Saini, Grigoriy Tchaga and Gordon Yan

Alterations in Immunophenotype of Autoimmune-prone Hypomorphic RAG-deficient Patients with CID-G/AI Phenotype
Thomas Pennix, Matthew Stowell, Boglarka Ujhazi, Taco Kuijpers, Olajumoke Fadugba, John Sleasman, Benedict Neven, Waleed Al-Herz, Manish Butte, Elisabeth G. Hoyte, Joseph D. Hernandez, Janet S. Chou9, Raif S. Geha, Luigi D. Notarangelo, Eric Meffre, Krisztian Csomos, Jolan E. Walter